Zehui He, Shuqi Jia, Mengsi Chen, Xinxin Shi, Lunuo Hu, Fei Li, Hui Shi, David C Nieman, Yue Shi
{"title":"Effects of exercise interventions on core health outcomes in patients with SLE: systematic review and meta-analysis.","authors":"Zehui He, Shuqi Jia, Mengsi Chen, Xinxin Shi, Lunuo Hu, Fei Li, Hui Shi, David C Nieman, Yue Shi","doi":"10.1136/lupus-2026-002027","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>This meta-analysis evaluated the effects of exercise interventions on key health outcomes in adults with SLE, including fatigue, physical function, aerobic capacity, disease activity, depression and pain.</p><p><strong>Methods: </strong>Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines, we systematically searched four databases up to February 2025 for randomised controlled trials (RCTs) in adults diagnosed with SLE according to the American College of Rheumatology/European Alliance of Associations for Rheumatology (ACR/EULAR) criteria. Eligible studies examined aerobic, resistance or combined exercise as the sole intervention. Meta-analyses were conducted using Hedges' g, the Risk of Bias 2 (ROB-2) tool and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system used to assess bias and evidence quality.</p><p><strong>Results: </strong>Twelve RCTs involving 470 participants were included. Exercise showed small-to-moderate improvements in fatigue (g=-0.53, 95% CI -0.81 to -0.25, p<0.001), physical function (g=0.46, 95% CI 0.23 to 0.68, p<0.001), aerobic capacity (g=0.47, 95% CI 0.22 to 0.71, p<0.001), depression (g=-0.36, 95% CI -0.64 to -0.09, p=0.01) and pain (g=-0.53, 95% CI -0.86 to -0.20, p<0.001), with no significant change in disease activity (g=0.18, 95% CI -0.16 to 0.51, p=0.30). Subgroup analyses suggested greater benefits with moderate-intensity programmes lasting 8-12 weeks. GRADE rated the evidence as moderate for fatigue, physical function, depression and pain, and low for other outcomes.</p><p><strong>Conclusion: </strong>Exercise is an effective non-pharmacological therapy in SLE management, improving several physical and psychological outcomes. Individualised, moderate-intensity and supervised programmes are recommended. Further research should optimise intervention protocols and evaluate long-term safety.</p><p><strong>Prospero registration number: </strong>CRD420251115953.</p>","PeriodicalId":18126,"journal":{"name":"Lupus Science & Medicine","volume":"13 1","pages":""},"PeriodicalIF":4.2000,"publicationDate":"2026-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13331240/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lupus Science & Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/lupus-2026-002027","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: This meta-analysis evaluated the effects of exercise interventions on key health outcomes in adults with SLE, including fatigue, physical function, aerobic capacity, disease activity, depression and pain.
Methods: Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines, we systematically searched four databases up to February 2025 for randomised controlled trials (RCTs) in adults diagnosed with SLE according to the American College of Rheumatology/European Alliance of Associations for Rheumatology (ACR/EULAR) criteria. Eligible studies examined aerobic, resistance or combined exercise as the sole intervention. Meta-analyses were conducted using Hedges' g, the Risk of Bias 2 (ROB-2) tool and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system used to assess bias and evidence quality.
Results: Twelve RCTs involving 470 participants were included. Exercise showed small-to-moderate improvements in fatigue (g=-0.53, 95% CI -0.81 to -0.25, p<0.001), physical function (g=0.46, 95% CI 0.23 to 0.68, p<0.001), aerobic capacity (g=0.47, 95% CI 0.22 to 0.71, p<0.001), depression (g=-0.36, 95% CI -0.64 to -0.09, p=0.01) and pain (g=-0.53, 95% CI -0.86 to -0.20, p<0.001), with no significant change in disease activity (g=0.18, 95% CI -0.16 to 0.51, p=0.30). Subgroup analyses suggested greater benefits with moderate-intensity programmes lasting 8-12 weeks. GRADE rated the evidence as moderate for fatigue, physical function, depression and pain, and low for other outcomes.
Conclusion: Exercise is an effective non-pharmacological therapy in SLE management, improving several physical and psychological outcomes. Individualised, moderate-intensity and supervised programmes are recommended. Further research should optimise intervention protocols and evaluate long-term safety.
期刊介绍：
Lupus Science & Medicine is a global, peer reviewed, open access online journal that provides a central point for publication of basic, clinical, translational, and epidemiological studies of all aspects of lupus and related diseases. It is the first lupus-specific open access journal in the world and was developed in response to the need for a barrier-free forum for publication of groundbreaking studies in lupus. The journal publishes research on lupus from fields including, but not limited to: rheumatology, dermatology, nephrology, immunology, pediatrics, cardiology, hepatology, pulmonology, obstetrics and gynecology, and psychiatry.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
